The largest database of trusted experimental protocols

Anti human il 4

Manufactured by Thermo Fisher Scientific
Sourced in United States

Anti-human IL-4 is a laboratory reagent used in immunological research and analysis. It is a monoclonal antibody that binds specifically to the human interleukin-4 (IL-4) cytokine. IL-4 plays a role in the regulation of immune responses and is involved in various biological processes. The Anti-human IL-4 reagent can be used for the detection, quantification, and isolation of IL-4 in samples.

Automatically generated - may contain errors

5 protocols using anti human il 4

1

CD4+ T Cell Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were incubated with CD4 microbeads (Miltenyi, German) according to manufacturer’s instructions. CD4 T cells positive separations were performed by MiniMACS ™ Separator. CD4 T cells were resuspended in RPMI1640 supplemented with 10% FBS, 1 mM l-glutamine, 55 uM β-Mercaptoethanol, 200U/ml penicillin, and 100 ug/ml streptomycin. The cells were seeded at 5 × 105/mL in 24-well plates which were precoated with 2 ug/ml anti-CD3 (BioGems, USA), and stimulated with 4 ug/ml anti-CD28 (BioGems, USA) and 10 ng/ml IL-2 (PeproTech, USA). IL-12 (50 ng/ml, PeproTech, USA) and anti-human IL-4 (10 ug/ml, PeproTech, USA) were used for T helper1 (Th1) culture. IL-4 (50 ng/ml, PeproTech, USA) and anti-human IFN-γ (10 ug/ml, PeproTech, USA) were used for Th2 culture. IL-6 (50 ng/ml, PeproTech, USA), IL-1β (10 ng/ml, PeproTech, USA), IL-23 (10 ng/ml, PeproTech, USA), TGF-β (10 ng/ml, PeproTech, USA), anti-human IFN-γ (10 ug/ml), and anti-human IL-4 (10 ug/ml) were used for Th17 culture. TGF-β (10 ng/ml), anti-human IFN-γ (10 ug/ml), and anti-human IL-4 (10 ug/ml) were used for regulatory T cells (Tregs) culture.
+ Open protocol
+ Expand
2

Isolation and HIV-1 Infection of Naïve CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Buffy coats of leukocytes were obtained from anonymous HIV- donors (New York Blood Center). Peripheral blood mononuclear cells (PBMCs) were harvested by density centrifugation with Ficoll-Paque (GE Healthcare). Naïve CD4+ T cells were isolated by MACS negative selection using the human naïve T-cell isolation kit (Miltenyi Biotec) to yield a population with the phenotype CD4+ CD45RA+ CD45RO CCR7+ CD62L+ CD27+ with purity levels equal or higher than 95%. Cells were then activated for 72 hours with beads coated with αCD3 and αCD28 antibodies, Dynabeads Human T-Activator CD3/CD28 for T cell Expansion and Activation, (ThermoFisher Scientific) under non-polarizing (NP) conditions, in the presence of 10 ng/ml of TGF-β1, 2 μg/ml of anti-Human IL-12 and 1 μg/ml of anti-Human IL-4 (all from Peprotech). Dynabeads were removed on day 3 and consequently cultured at a density of 1 × 106 cells/ml in complete medium with 30 IU/ml of rhIL-2 (R&D Systems). Cells were infected by spinoculation on Day 5: 106 cells were infected with 300 ng/mL p24 for 2 hours at 2900 rpm and 37 °C in 1 mL. After infection, cells kept in culture at 1 × 106 cells/ml in complete medium with 30 IU/ml of rhIL-2 at 37 °C for 7 days prior to further experimentation, during which actively infected cells die, leaving a mixed population of latently infected or uninfected cells.
+ Open protocol
+ Expand
3

Th1 Polarization of Murine and Human CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naïve CD4+ T cells were cultured in Th1-polarizing conditions for 96 hrs. The following antibodies were used for murine cells: 50ng ml−1 recombinant mouse IL-2, 50ng ml−1 recombinant mouse IL-12 and 10 μg ml−1 anti-mouse IL-4 (all eBioscience, CA, USA); for human cells we used: 50ng ml−1 recombinant human IL-2, 50ng ml−1 recombinant human IL-12 and 10 μg ml−1 anti-human IL-4 (all eBioscience, CA, USA). As controls, naïve CD4+ T cells were cultured with recombinant mouse IL-2 (50ng ml−1) to maintain T cell survival. After 96 hrs, supernatant and murine cells were analyzed by ELISA and flow cytometry, respectively. After 12 days, supernatant and human cells were analyzed by ELISA and flow cytometry, respectively.
+ Open protocol
+ Expand
4

Regulatory T Cell Induction Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified anti-human CD3 (OKT3) and purified anti-human CD28 (CD28.2) were purchased from eBioscience. All fluorochrome-conjugated antibodies (anti-human CD4 (RPA-T4), anti-human CD45RA (HI100), anti-human CD25 (BC96), anti-human FoxP3 (PCH101), anti-human IFNγ, anti-human IL-4, anti-human IL-17, and anti-mouse IL-6 were from eBioscience. Recombinant human IL-2 (202-IL), human TGFβ1 (240-B), and human latent TGFβ1 (299-LT) were purchased from R&D Systems. Anti-TGFβ (1D11.16.8), anti-CD25 (PC-61.5.3), and their isotype control antibodies (MOPC-21, HRPN) were from Bio X Cell. PGE2, TGFβ, and IL-6 ELISA Ready-SET-Go! kits were purchased from eBioscience.
+ Open protocol
+ Expand
5

Fibroblast Response to ILC2 Stimuli

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human lung fibroblasts, fetal (Sigma) were cultured in DMEM/F12 medium (Gibco) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 1% P/S, 0.5% L-glutamine and 0.2% amphotericin B and were maintained at 37°C in a humidified incubator containing 5% CO2. Prior to stimulation, 1 × 105 fibroblasts were seeded per well of 6 well-plates and rested in 0.1% FBS overnight. Fibroblasts were then stimulated for 48 h with fresh medium supplemented with rh IL-4 (1 pg/ml and 5 pg/ml, Immunotools) and rh IL-13 (10 ng/ml, Immunotools) or 1:5 diluted conditioned ILC2 supernatants derived from ex vivo stimulated human ILC2s (collected between d11 to d15 or after 3 days of restimulating adjusted numbers of expanded ILC2s). When indicated, anti-human IL-4 (10 ng/ml, eBioscience), anti-human IL-13 (20 ng/ml, BioLegend) or combinations of these were added. Conditioned supernatant derived from stimulated feeder cells alone or 1:5 diluted Yssel's medium (1% human serum AB, 1% P/S) supplemented with the cytokine cocktails used for ILC2 expansion (PHA, IL-2, IL-33 and IL-25) or restimulation (IL-2, IL-33, and IL-25) served as control. Fibroblasts up to passage eleven were used.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!